A detailed history of Xtx Topco LTD transactions in Mannkind Corp stock. As of the latest transaction made, Xtx Topco LTD holds 25,664 shares of MNKD stock, worth $141,921. This represents 0.02% of its overall portfolio holdings.

Number of Shares
25,664
Holding current value
$141,921
% of portfolio
0.02%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$3.25 - $5.27 $83,408 - $135,249
25,664 New
25,664 $116,000
Q1 2023

May 12, 2023

BUY
$3.95 - $5.63 $41,672 - $59,396
10,550 New
10,550 $43,000
Q3 2022

Nov 14, 2022

BUY
$2.99 - $4.35 $88,683 - $129,020
29,660 New
29,660 $92,000
Q2 2021

Aug 12, 2021

SELL
$3.61 - $5.45 $48,911 - $73,842
-13,549 Closed
0 $0
Q1 2021

May 14, 2021

BUY
$3.14 - $6.14 $42,543 - $83,190
13,549 New
13,549 $53,000

Others Institutions Holding MNKD

About MANNKIND CORP


  • Ticker MNKD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 257,338,000
  • Market Cap $1.42B
  • Description
  • MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...
More about MNKD
Track This Portfolio

Track Xtx Topco LTD Portfolio

Follow Xtx Topco LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

News

Stay updated on Xtx Topco LTD with notifications on news.